Mountaineer Study News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Mountaineer Study. Real-time updates on events, politics, business and more.

HER2+ Metastatic Colorectal Cancer: Clinical Trial Data With Tucatinib

July 19, 2023

A panel of oncologists shares comprehensive insight to clinical trial data with tucatinib in patients with HER2+ metastatic colorectal cancer.

Evolving Testing Treatment Strategies Metastatic Colorectal Cancer Clinical Trial Data With Tucatinib Colorectal Cancer Her2 Positive

Source: onclive.com

Dr Foote on the Use of Tucatinib Plus Trastuzumab in HER2-Amplified mCRC

April 10, 2023

Micheal Foote, MD, discusses the use of tucatinib plus trastuzumab compared with chemotherapy in the management of HER2-amplified metastatic colorectal cancer.

Michael Foote Memorial Sloan Kettering Cancer Center Metastatic Colorectal Cancer Her2 Amplified Metastatic Colorectal Cancer Mountaineer Study

Source: onclive.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Mountaineer Study News Today

HER2+ Metastatic Colorectal Cancer: Clinical Trial Data With Tucatinib

Dr Foote on the Use of Tucatinib Plus Trastuzumab in HER2-Amplified mCRC

Explore More Categories